Top compounds associated with response to OR4K13


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.036 0.3
mRNA XMD8-85 GDSC1000 pan-cancer AAC 0.056 0.3
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.034 0.3
mRNA BRD-K96431673 CTRPv2 pan-cancer AAC -0.078 0.3
mRNA L-685458 CTRPv2 pan-cancer AAC -0.04 0.3
mRNA EHT 1864 GDSC1000 pan-cancer AAC 0.038 0.3
mRNA BX-795 GDSC1000 pan-cancer AAC -0.037 0.3
mRNA CAL-101 GDSC1000 pan-cancer AAC 0.035 0.3
mRNA clofarabine CTRPv2 pan-cancer AAC 0.031 0.3
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC -0.04 0.3
Download CSV